	Drug_id	Drug_name	Indication
0	DB00002	Cetuximab	Metastatic Colorectal Cancers
1	DB00002	Cetuximab	Metastatic Squamous Cell Carcinoma of the Head and Neck
2	DB00002	Cetuximab	Advanced squamous cell carcinoma of the head and neck
3	DB00003	Dornase alfa	Cystic Fibrosis (CF)
4	DB00004	Denileukin diftitox	Cutaneous T-Cell Lymphoma (CTCL)
5	DB00005	Etanercept	Ankylosing Spondylitis (AS)
6	DB00005	Etanercept	Graft Versus Host Disease (GVHD)
7	DB00005	Etanercept	Hidradenitis Suppurativa (HS)
8	DB00005	Etanercept	Polyarticular Juvenile Idiopathic Arthritis
9	DB00005	Etanercept	Psoriasis Vulgaris (Plaque Psoriasis)
10	DB00005	Etanercept	Psoriatic Arthritis
11	DB00005	Etanercept	Pyoderma Gangrenosum
12	DB00005	Etanercept	Rheumatoid Arthritis
13	DB00005	Etanercept	Severe, active Rheumatoid arthritis
14	DB00006	Bivalirudin	Acute Coronary Syndromes (ACS)
15	DB00006	Bivalirudin	Thrombotic events
16	DB00007	Leuprolide	Advanced Prostate Cancer
17	DB00007	Leuprolide	Breast Cancer
18	DB00007	Leuprolide	Central Precocious Puberty (CPP)
19	DB00007	Leuprolide	Endometriosis
20	DB00007	Leuprolide	Infertilities
21	DB00007	Leuprolide	Pain
22	DB00007	Leuprolide	Paraphilia
23	DB00007	Leuprolide	Uterine Leiomyomas
24	DB00007	Leuprolide	Symptom recurrence
25	DB00008	Peginterferon alfa-2a	Hepatitis B Chronic Infection
26	DB00008	Peginterferon alfa-2a	Compensated liver disease
27	DB00009	Alteplase	Acute Ischemic Stroke (AIS)
28	DB00009	Alteplase	Acute Myocardial Infarction (AMI)
29	DB00009	Alteplase	Acute massive pulmonary embolism
30	DB00009	Alteplase	Central venous access device thrombosis
31	DB00012	Darbepoetin alfa	Anemias
32	DB00014	Goserelin	Advanced Breast Cancer
33	DB00014	Goserelin	Endometriosis
34	DB00014	Goserelin	Stage I Breast Carcinoma
35	DB00014	Goserelin	Advanced carcinoma of the prostate
36	DB00014	Goserelin	Stage M1 hormone dependent carcinoma of the prostate
37	DB00014	Goserelin	Stage T2b carcinoma of the prostate
38	DB00014	Goserelin	Stage T2c carcinoma of the prostate
39	DB00014	Goserelin	Stage T3 carcinoma of the prostate
40	DB00014	Goserelin	Stage T4 carcinoma of the prostate
41	DB00014	Goserelin	Endometrial thinning prior to endometrial ablation for dysfunctional uterine bleeding
42	DB00015	Reteplase	Acute Myocardial Infarction (AMI)
43	DB00015	Reteplase	Cardiovascular Mortality
44	DB00015	Reteplase	Congestive Heart Failure
45	DB00016	Erythropoietin	Anemia caused by Zidovudine
46	DB00016	Erythropoietin	Anemias
47	DB00016	Erythropoietin	Reduction of allogeneic RBC transfusions in patients undergoing elective, noncardiac, nonvascular surgery
48	DB00017	Salmon Calcitonin	Hypercalcemia
49	DB00017	Salmon Calcitonin	Osteoporosis
50	DB00017	Salmon Calcitonin	Symptomatic Paget's disease
51	DB00018	Interferon alfa-n3	Refractory Condylomata acuminata of the external
52	DB00019	Pegfilgrastim	Chemotherapy Induced Neutropenia
53	DB00019	Pegfilgrastim	Hematopoietic Subsyndrome of Acute Radiation Syndrome
54	DB00019	Pegfilgrastim	Infection NOS
55	DB00020	Sargramostim	Bone Marrow Suppression
56	DB00020	Sargramostim	Delayed engraftment
57	DB00020	Sargramostim	Graft Failure
58	DB00020	Sargramostim	Neutropenia
59	DB00020	Sargramostim	Mobilization of hematopoietic progenitor cells into peripheral blood for collection by leukapheresis therapy
60	DB00022	Peginterferon alfa-2b	Chronic Hepatitis C Virus (HCV) Infection
61	DB00022	Peginterferon alfa-2b	Melanoma
62	DB00023	Asparaginase Escherichia coli	Acute Lymphoblastic Leukaemias (ALL)
63	DB00024	Thyrotropin alfa	Thyroid Cancers
64	DB00024	Thyrotropin alfa	Thyroid tissue remnants
65	DB00024	Thyrotropin alfa	Radioiodine ablation of thyroid tissue
66	DB00025	Antihemophilic factor, human recombinant	Bleeding
67	DB00025	Antihemophilic factor, human recombinant	Hemophilia A
68	DB00025	Antihemophilic factor, human recombinant	Postoperative Hemorrhages
69	DB00025	Antihemophilic factor, human recombinant	Bleeding in invasive procedures
70	DB00025	Antihemophilic factor, human recombinant	Perioperative procedures
71	DB00026	Anakinra	Juvenile Idiopathic Arthritis (JIA)
72	DB00026	Anakinra	Neonatal-onset multisystemic inflammatory disease
73	DB00026	Anakinra	Moderate Rheumatoid arthritis
74	DB00026	Anakinra	Recurrent Pericarditis
75	DB00026	Anakinra	Severe Rheumatoid arthritis
76	DB00027	Gramicidin D	Superficial Eye Infections
77	DB00028	Immune globulin human	B-Cell Chronic Lymphocytic Leukemia
78	DB00028	Immune globulin human	Bruton's agammaglobulinemia
79	DB00028	Immune globulin human	Chronic Idiopathic Thrombocytopenic Purpura
80	DB00028	Immune globulin human	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
81	DB00028	Immune globulin human	Common Variable Immunodeficiency
82	DB00028	Immune globulin human	Congenital Immunodeficiency
83	DB00028	Immune globulin human	Kawasaki Syndrome
84	DB00028	Immune globulin human	Wiskott-Aldrich Syndrome (WAS)
85	DB00030	Insulin human	Diabetes Mellitus (DM)
86	DB00031	Tenecteplase	ST Elevation Myocardial Infarction (STEMI)
87	DB00032	Menotropins	Assisted Reproductive Technology therapy
88	DB00033	Interferon gamma-1b	Chronic Granulomatous Disease (CGD)
89	DB00033	Interferon gamma-1b	Severe, malignant Osteopetrosis
90	DB00035	Desmopressin	Bleeding
91	DB00035	Desmopressin	Central Diabetes Insipidus
92	DB00035	Desmopressin	Nocturia
93	DB00035	Desmopressin	Polydipsia
94	DB00035	Desmopressin	Polyuria
95	DB00035	Desmopressin	Primary Nocturnal Enuresis
96	DB00036	Coagulation factor VIIa Recombinant Human	Bleeding
97	DB00038	Oprelvekin	Thrombocytopenia
98	DB00039	Palifermin	Oral Mucositis
99	DB00040	Glucagon	Severe Hypoglycemia
100	DB00041	Aldesleukin	High Risk Neuroblastoma
101	DB00041	Aldesleukin	Metastatic Melanoma
102	DB00041	Aldesleukin	Metastatic Renal Cell Carcinoma
103	DB00042	Botulinum Toxin Type B	Cervical Dystonia
104	DB00042	Botulinum Toxin Type B	Sialorrhea
105	DB00043	Omalizumab	Chronic Idiopathic Urticaria
106	DB00043	Omalizumab	Moderate Asthma
107	DB00043	Omalizumab	Severe Asthma
108	DB00044	Lutropin alfa	Hypogonadism
109	DB00044	Lutropin alfa	Infertilities
110	DB00046	Insulin lispro	Diabetes Mellitus (DM)
111	DB00046	Insulin lispro	Diabetic Ketoacidosis
112	DB00046	Insulin lispro	Gestational Diabetes Mellitus (GDM)
113	DB00046	Insulin lispro	Hyperglycemias
114	DB00047	Insulin glargine	Diabetes Mellitus (DM)
115	DB00047	Insulin glargine	Hyperglycemias
116	DB00047	Insulin glargine	Type 2 Diabetes Mellitus
117	DB00048	Collagenase clostridium histolyticum	Dupuytrenâ€™s Contracture
118	DB00048	Collagenase clostridium histolyticum	Peyronie's Disease
119	DB00048	Collagenase clostridium histolyticum	Necrotic tissue
120	DB00049	Rasburicase	Hyperuricemia
121	DB00050	Cetrorelix	Controlled Ovarian Stimulation
122	DB00051	Adalimumab	Crohn's Disease (CD)
123	DB00051	Adalimumab	Non-infectious Intermediate, Posterior and Panuveitis
124	DB00051	Adalimumab	Pediatric Crohn's Disease
125	DB00051	Adalimumab	Psoriatic arthritis aggravated
126	DB00051	Adalimumab	Pyoderma Gangrenosum
127	DB00051	Adalimumab	Severe Plaque psoriasis
128	DB00051	Adalimumab	Severe Ulcerative Colitis
129	DB00051	Adalimumab	Active Ankylosing spondylitis
130	DB00051	Adalimumab	Moderate Hidradenitis Suppurativa
131	DB00051	Adalimumab	Moderate Juvenile idiopathic arthritis
132	DB00051	Adalimumab	Moderate Plaque psoriasis
133	DB00051	Adalimumab	Moderate Rheumatoid arthritis
134	DB00051	Adalimumab	Moderate Ulcerative colitis
135	DB00051	Adalimumab	Severe Hidradenitis Suppurativa
136	DB00051	Adalimumab	Severe Juvenile idiopathic arthritis
137	DB00051	Adalimumab	Severe Rheumatoid arthritis
138	DB00052	Somatotropin	Adult Onset Growth Hormone Deficiency
139	DB00052	Somatotropin	Cachexia
140	DB00052	Somatotropin	Childhood-onset Growth Hormone Deficiency
141	DB00052	Somatotropin	Growth Failure
142	DB00052	Somatotropin	Short Bowel Syndrome (SBS)
143	DB00052	Somatotropin	Short Stature
144	DB00053	Imiglucerase	Gaucher's Disease Type 1
145	DB00053	Imiglucerase	Type 3 Gaucher disease
146	DB00054	Abciximab	Thrombotic events
147	DB00056	Gemtuzumab ozogamicin	Leukemia Acute Myeloid Leukemia (AML)
148	DB00056	Gemtuzumab ozogamicin	Refractory Acute Myeloid Leukemia
149	DB00056	Gemtuzumab ozogamicin	Relapsed Acute Myeloid Leukemia
150	DB00058	Alpha-1-proteinase inhibitor	Emphysema
151	DB00059	Pegaspargase	Acute Lymphoblastic Leukaemias (ALL)
152	DB00060	Interferon beta-1a	Relapsing Remitting Multiple Sclerosis (RRMS)
153	DB00061	Pegademase	Adenosine Deaminase Deficiency
154	DB00062	Human Serum Albumin	Acute Pyelonephritis
155	DB00062	Human Serum Albumin	Allergies
156	DB00062	Human Serum Albumin	Hypoalbuminemia
157	DB00062	Human Serum Albumin	Hypoproteinemia
158	DB00062	Human Serum Albumin	Hypovolaemia
159	DB00062	Human Serum Albumin	Hypovolemic Shock
160	DB00062	Human Serum Albumin	Acute fulminant liver failure
161	DB00062	Human Serum Albumin	Central volume depletion
162	DB00062	Human Serum Albumin	Hyperbilirubinemia in neonates
163	DB00062	Human Serum Albumin	Post-operative albumin loss
164	DB00063	Eptifibatide	Acute Coronary Syndromes (ACS)
165	DB00063	Eptifibatide	Thrombotic events
166	DB00065	Infliximab	Ankylosing Spondylitis (AS)
167	DB00065	Infliximab	Crohn's Disease (CD)
168	DB00065	Infliximab	Psoriasis Vulgaris (Plaque Psoriasis)
169	DB00065	Infliximab	Psoriatic Arthritis
170	DB00065	Infliximab	Rheumatoid Arthritis
171	DB00065	Infliximab	Ulcerative Colitis
172	DB00066	Follitropin	Assisted Reproductive Technology therapy
173	DB00066	Follitropin	Ovulation induction therapy
174	DB00066	Follitropin	Stimulation of spermatogenesis therapy
175	DB00067	Vasopressin	Acute Circulatory Failure
176	DB00068	Interferon beta-1b	Relapsing Remitting Multiple Sclerosis (RRMS)
177	DB00068	Interferon beta-1b	Secondary Progressive Multiple Sclerosis (SPMS)
178	DB00070	Hyaluronidase (ovine)	Chronic Lymphocytic Leukaemia (CLL)
179	DB00070	Hyaluronidase (ovine)	Follicular Lymphoma (FL)
180	DB00070	Hyaluronidase (ovine)	Lymphoma, Large B-Cell, Diffuse (DLBCL)
181	DB00070	Hyaluronidase (ovine)	Refractory Follicular Lymphoma
182	DB00070	Hyaluronidase (ovine)	Relapsed Follicular Lymphoma
183	DB00070	Hyaluronidase (ovine)	Non-progressive Follicular Lymphoma
184	DB00070	Hyaluronidase (ovine)	Stable Follicular Lymphoma
185	DB00070	Hyaluronidase (ovine)	Parenteral rehydration therapy
186	DB00070	Hyaluronidase (ovine)	In subcutaneous urography for improving resorption of radiopaque agents
187	DB00070	Hyaluronidase (ovine)	To increase percutaneous drug absorption
188	DB00071	Insulin Pork	Type 1 Insulin-Dependent Diabetes Mellitus
189	DB00072	Trastuzumab	Breast Cancer
190	DB00072	Trastuzumab	Metastatic Adenocarcinoma of the Gastro-Esophageal Junction
191	DB00072	Trastuzumab	Metastatic Adenocarcinoma of the Stomach
192	DB00072	Trastuzumab	Metastatic Breast Cancer (MBC)
193	DB00072	Trastuzumab	Metastatic Gastroesophageal Junction Adenocarcinoma
194	DB00073	Rituximab	Chronic Lymphocytic Leukaemia (CLL)
195	DB00073	Rituximab	Granulomatosis With Polyangiitis
196	DB00073	Rituximab	Granulomatosis With Polyangiitis (GPA)
197	DB00073	Rituximab	Microscopic Polyangiitis
198	DB00073	Rituximab	Microscopic Polyangiitis (MPA)
199	DB00073	Rituximab	Non-Hodgkin's Lymphoma (NHL)
200	DB00073	Rituximab	Pemphigus Vulgaris (PV)
201	DB00073	Rituximab	Moderate Rheumatoid arthritis
202	DB00073	Rituximab	Moderate to severe pemphigus vulgaris
203	DB00073	Rituximab	Severe Rheumatoid arthritis
204	DB00074	Basiliximab	Kidney Transplant Rejection
205	DB00075	Muromonab	Kidney Transplant Rejection
206	DB00075	Muromonab	Steroid resistant Heart transplant rejection
207	DB00075	Muromonab	Steroid resistant hepatic transplant rejection
208	DB00076	Digoxin Immune Fab (Ovine)	Digoxin toxicity
209	DB00076	Digoxin Immune Fab (Ovine)	Digoxin overdose
210	DB00078	Ibritumomab tiuxetan	Follicular Non-Hodgkin's Lymphoma
211	DB00078	Ibritumomab tiuxetan	Follicular Non-Hodgkin's Lymphoma Refractory
212	DB00080	Daptomycin	Bacteremia
213	DB00080	Daptomycin	Skin and Subcutaneous Tissue Bacterial Infections
214	DB00080	Daptomycin	Right-sided Infective pericarditis
215	DB00082	Pegvisomant	Acromegaly
216	DB00083	Botulinum toxin type A	Blepharospasm
217	DB00083	Botulinum toxin type A	Cervical Dystonia
218	DB00083	Botulinum toxin type A	Chronic Migraine
219	DB00083	Botulinum toxin type A	Equinus deformity of foot, acquired
220	DB00083	Botulinum toxin type A	Lower Limb Spasticity
221	DB00083	Botulinum toxin type A	Sialorrhea
222	DB00083	Botulinum toxin type A	Strabismus
223	DB00083	Botulinum toxin type A	Upper Limb Spasticity
224	DB00083	Botulinum toxin type A	Urinary Bladder, Overactive
225	DB00083	Botulinum toxin type A	Urinary Incontinence (UI)
226	DB00083	Botulinum toxin type A	Detrusor overactivity, neurologic conditions
227	DB00083	Botulinum toxin type A	Hypertonicity disorders of the 7th nerve
228	DB00083	Botulinum toxin type A	Severe axillary hyperhidrosis
229	DB00083	Botulinum toxin type A	Temporary improvement in the appearance of moderate to severe lateral canthal lines associated with orbicularis oculi activity
230	DB00083	Botulinum toxin type A	Temporary improvement in the appearance of moderate to severe glabellar lines associated with procerus and corrugator muscle activity
231	DB00085	Pancrelipase	Diarrhea
232	DB00085	Pancrelipase	Exocrine Pancreatic Insufficiency
233	DB00085	Pancrelipase	Gastrointestinal Discomfort
234	DB00085	Pancrelipase	Fat malabsorption
235	DB00087	Alemtuzumab	Autoimmune Hemolytic Anemia
236	DB00087	Alemtuzumab	B-Cell Chronic Lymphocytic Leukemia
237	DB00087	Alemtuzumab	Graft Versus Host Disease (GVHD)
238	DB00087	Alemtuzumab	Kidney Transplant Rejection
239	DB00087	Alemtuzumab	Relapsing Remitting Multiple Sclerosis (RRMS)
240	DB00087	Alemtuzumab	T-Cell Prolymphocytic Leukemia
241	DB00087	Alemtuzumab	Conditioning regimens for allogeneic stem cell transplantation therapy
242	DB00089	Capromab pendetide	Prostate Cancer
243	DB00090	Laronidase	Type 1 Mucopolysaccharidosis
244	DB00091	Cyclosporine	Atopic Dermatitis (AD)
245	DB00091	Cyclosporine	Bone Marrow Transplant Rejection
246	DB00091	Cyclosporine	Connective Tissue Disorders
247	DB00091	Cyclosporine	Glomerulonephritis minimal lesion
248	DB00091	Cyclosporine	Glomerulosclerosis, Focal Segmental
249	DB00091	Cyclosporine	Graft Versus Host Disease (GVHD)
250	DB00091	Cyclosporine	Heart Transplant Rejection
251	DB00091	Cyclosporine	Idiopathic Thrombocytopenic Purpura
252	DB00091	Cyclosporine	Interstitial Cystitis
253	DB00091	Cyclosporine	Juvenile Idiopathic Arthritis (JIA)
254	DB00091	Cyclosporine	Kidney Transplant Rejection
255	DB00091	Cyclosporine	Liver Transplant Rejection
256	DB00091	Cyclosporine	Nephritis, Lupus
257	DB00091	Cyclosporine	Ocular Rosacea
258	DB00091	Cyclosporine	Psoriasis
259	DB00091	Cyclosporine	Severe Ulcerative Colitis
260	DB00091	Cyclosporine	Uveitis
261	DB00091	Cyclosporine	Blistering disorder
262	DB00091	Cyclosporine	Refractory Ulcerative colitis
263	DB00091	Cyclosporine	Severe, active Rheumatoid arthritis
264	DB00091	Cyclosporine	Severe, recalcitrant Plaque psoriasis
265	DB00091	Cyclosporine	Suppressed tear production
266	DB00094	Urofollitropin	Infertilities
267	DB00094	Urofollitropin	Assisted Reproductive Technology therapy
268	DB00094	Urofollitropin	Ovulation induction therapy
269	DB00097	Choriogonadotropin alfa	Assisted Reproductive Technology therapy
270	DB00097	Choriogonadotropin alfa	Ovulation induction therapy
271	DB00098	Antithymocyte immunoglobulin (rabbit)	Acute cellular rejection
272	DB00098	Antithymocyte immunoglobulin (rabbit)	Antibody-mediated Rejection
273	DB00098	Antithymocyte immunoglobulin (rabbit)	Kidney Transplant Rejection
274	DB00098	Antithymocyte immunoglobulin (rabbit)	Myelodysplastic Syndrome
275	DB00098	Antithymocyte immunoglobulin (rabbit)	Induction therapy in renal transplantation
276	DB00099	Filgrastim	Hematopoietic Subsyndrome of Acute Radiation Syndrome
277	DB00099	Filgrastim	Neutropenia
278	DB00099	Filgrastim	Neutropenia, Febrile
279	DB00099	Filgrastim	Neutropenia aggravated
280	DB00099	Filgrastim	Neutropenia-related sequelae
281	DB00099	Filgrastim	Neutrophil suppression
282	DB00099	Filgrastim	Severe idiopathic neutropenia
283	DB00099	Filgrastim	Mobilization of autologous hematopoietic progenitor cells into the peripheral blood for collection by leukapheresis
284	DB00100	Coagulation Factor IX (Recombinant)	Hereditary factor IX deficiency
285	DB00102	Becaplermin	Skin Ulcer
286	DB00103	Agalsidase beta	Fabry's Disease
287	DB00104	Octreotide	Acromegaly
288	DB00104	Octreotide	Metastatic Carcinoid Tumors
289	DB00104	Octreotide	Profuse watery diarrhea
290	DB00105	Interferon alfa-2b	Chronic Hepatitis C Virus (HCV) Infection
291	DB00105	Interferon alfa-2b	Hairy Cell Leukemia (HCL)
292	DB00105	Interferon alfa-2b	Kaposi s Sarcoma (KS)
293	DB00105	Interferon alfa-2b	Malignant Melanoma
294	DB00107	Oxytocin	Abortion induced incomplete
295	DB00107	Oxytocin	Inevitable abortion
296	DB00107	Oxytocin	Postpartum Bleeding
297	DB00107	Oxytocin	Induction of Uterine contractions
298	DB00107	Oxytocin	Reinforcement of labor
299	DB00108	Natalizumab	Relapsing Remitting Multiple Sclerosis (RRMS)
